Skip to content
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
IFPMA
  • Who We Are
    • IFPMA in Brief
    • Our Governance and Leadership
    • Our Membership
      • Full Members
        • Associations
        • Companies
      • Affiliate Members
    • Our Experts
    • Join Us
  • Topics
  • News Center
    • News Releases
    • Blog
      • Global Health Matters
      • Science Matters
      • DG’s Column
    • Statements
    • Latest News from Our Members
  • Resources
    • Publications
      • News Releases
      • Statements
      • Position Papers
      • Publications
      • External Studies
      • Infographics
      • Event Highlights
    • Multimedia
      • Interviews
      • Videos
      • Slides
    • IFPMA Interactive Platforms
      • IFPMA COVID-19 Hub
      • Global Health Progress
      • 50 Years of Global Health Progress
  • Events
    • Upcoming IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
    • Past IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
  • Partners
  • BCR
  • Inventing Medicines and Vaccines
  • Strengthening Regulatory Systems
  • Ethics and Business Integrity
  • Boosting Innovation and Access
  • Tackling Global health challenges
Climate change Economic footprint IP Sustainable innovation Value of innovation

spotlight

Value of innovation

Inventing Medicines and Vaccines
African Medicines Agency Biosimilars Biotherapeutic medicines Falsified medicines Import testing Pharmacovigiliance Quality, safety, and efficacy Regulatory conferences Regulatory system strengthening / Harmonization Supply chain The Africa Regulatory Network (ARN) The ARN: Le réseau africain de réglementation pharmaceutique

spotlight

Pharmacovigiliance

Strengthening Regulatory Systems
IFPMA Code of Practice (2019) Our Ethos Code eLearning Tool IFPMA Notes for Guidance IFPMA Complaint Operating Procedure How to File a Code Complaint Complaint Submission Form Cases Business Ethics for APEC SMEs Initiative Consensus Framework for Ethical Collaboration

spotlight

IFPMA Code of Practice (2019)

Ethics and Business Integrity
Access to medicines Health technology assessment IP Trade

spotlight

Access to medicines

Boosting Innovation and Access
Ageing Antimicrobial resistance Cancer Child and maternal health Diabetes Do you mind? campaign Ebola Falsified medicines Health partnerships HIV/AIDS Humanitarian and disaster relief aid Influenza Malaria Mental and neurological disorders Neglected tropical diseases Non-communicable diseases Novel Coronavirus (COVID-19) Pandemic Preparedness Psoriasis Public health implications of the implementation of the Nagoya Protocol Rare diseases Supply chain Sustainable development goals Tuberculosis Universal Health Coverage Vaccination confidence Vaccines innovation Vaccines protect communities Vaccines sustainability Value of immunization Viral hepatitis Workplace wellness Zika Virus

spotlight

Universal Health Coverage

Tackling Global health challenges
  • Home
  • >
  • Resources
  • >
  • Position Papers
  • >
  • Preparing society against future pandemics - Policy Perspectives from the Innovative Biopharmaceutical Industry

Preparing society against future pandemics – Policy Perspectives from the Innovative Biopharmaceutical Industry

Published on: 18 October 2021

Downloads

» IFPMA_Preparing_society_against_future_pandemics_In_Brief
» IFPMA_Preparing_society_against_future_pandemics_Full_Report

Resources

Bolstering action against future pandemics: pharma policy perspectives on delivering medical countermeasures
News Releases

News Releases

Bolstering action against future pandemics: pharma policy perspectives on delivering medical countermeasures

Innovative biopharmaceutical industry welcomes the G7 agreement to work in partnership with the private sector towards a 100 Days Mission to improve readiness for future pandemics
Statements

Statements

Innovative biopharmaceutical industry welcomes the G7 agreement to work in partnership with the private sector towards a 100 Days Mission to improve readiness for future pandemics

WHA 74 – IFPMA-ICBA-GSCF Statement on agenda item 17
Statements

Statements

WHA 74 – IFPMA-ICBA-GSCF Statement on agenda item 17

Global biopharmaceutical industry sees upcoming World Health Assembly as a critical milestone to take stock of progress achieved and discuss enablers for future pandemic preparedness
News Releases

News Releases

Global biopharmaceutical industry sees upcoming World Health Assembly as a critical milestone to take stock of progress achieved and discuss enablers for future pandemic preparedness

The Nagoya Protocol and Pathogen Sharing (Video)
Videos

Videos

The Nagoya Protocol and Pathogen Sharing (Video)

Related Blog Entries

Learning from COVID-19 – from panic to preparedness

Learning from COVID-19 – from panic to preparedness

Related Topics

Pandemic Preparedness

Tags

  • global health security
  • Pandemic prepardness
IFPMA

Chemin des Mines 9
1202 Geneva
Switzerland

+41 22 338 32 00
info@ifpma.org

  • File a Code Complaint
  • Privacy Policy
  • Terms of Use
  • Access to Our Extranet
  • Careers
  • Contact Us
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
Designed and Produced by ACW
^ Back to Top